KAPSPARGO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kapspargo, and when can generic versions of Kapspargo launch?
Kapspargo is a drug marketed by Spil and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in KAPSPARGO is metoprolol succinate. There are sixty drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Kapspargo
A generic version of KAPSPARGO was approved as metoprolol succinate by ACTAVIS LABS FL INC on August 3rd, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KAPSPARGO?
- What are the global sales for KAPSPARGO?
- What is Average Wholesale Price for KAPSPARGO?
Summary for KAPSPARGO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for KAPSPARGO |
| What excipients (inactive ingredients) are in KAPSPARGO? | KAPSPARGO excipients list |
| DailyMed Link: | KAPSPARGO at DailyMed |
US Patents and Regulatory Information for KAPSPARGO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-001 | Jan 26, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-004 | Jan 26, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-002 | Jan 26, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-004 | Jan 26, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-001 | Jan 26, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
